Form 4: SAB Biotherapeutics Director David Charles Link Acquires Stock Options

Director David Charles Link acquired stock options in SAB Biotherapeutics, Inc. as part of his annual board grant and a one-time grant.

Summary

• On July 15, 2024, David Charles Link, a director of SAB Biotherapeutics, Inc. (SABS), acquired stock options.
• He received an annual grant of options for 20,000 shares and a one-time grant of options for 9,305 shares.
• Both grants have an exercise price of $2.90 per share and expire on July 15, 2034.
• The annual grant vests in two equal annual installments starting July 15, 2025, and the one-time grant vests in three equal annual installments starting July 15, 2025.
• Following the transaction, Link directly owns options for 29,305 shares of SAB Biotherapeutics common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to stock option grants, which is a standard practice. There's no indication of positive or negative news.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the options suggest a multi-year commitment from the director.

Industry Context

Stock option grants are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Director compensation packages, including stock options, vary widely across the biotechnology industry depending on company size, stage of development, and performance.
• Comparing SAB Biotherapeutics' director compensation to peers like Vir Biotechnology or Adaptive Biotechnologies would provide a better understanding of whether these grants are in line with industry norms.
• The vesting schedules are fairly standard, aligning with typical long-term incentive plans.

Stakeholder Impact

• The granting of stock options aligns the director's interests with those of shareholders, potentially incentivizing actions that increase shareholder value.

Key Dates